Scientific article
English

Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease

Published in

Neurology, vol. 80, no. 11, p. 1048-1056

Publication date

2013

Abstract

The current model of Alzheimer disease (AD) stipulates that brain amyloidosis biomarkers turn abnormal earliest, followed by cortical hypometabolism, and finally brain atrophy ones. The aim of this study is to provide clinical evidence of the model in patients with mild cognitive impairment (MCI).

Keywords

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease/cerebrospinal fluid/diagnosis/pathology
  • Amyloid beta-Peptides/cerebrospinal fluid
  • Atrophy
  • Biomarkers/cerebrospinal fluid
  • Brain/pathology
  • Cognitive Dysfunction/cerebrospinal fluid/diagnosis/pathology
  • Dementia/diagnosis/pathology
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Peptide Fragments/cerebrospinal fluid
  • Predictive Value of Tests
  • tau Proteins/cerebrospinal fluid

UNIGE affiliation entities

Not a UNIGE publication

Citation (ISO format)

PRESTIA, Annapaola et al. Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease. In: Neurology, 2013, vol. 80, n° 11, p. 1048–1056. doi: 10.1212/WNL.0b013e3182872830

Main files (1)

Article (Published version)

Identifiers

Additional URL for this publication

https://n.neurology.org/content/80/11/1048

Journal ISSN

0028-3878
286views
0downloads

Technical informations

Creation

16/02/2021 12:26:00

First validation

16/02/2021 12:26:00

Update

16/03/2023 00:06:50

Status update

16/03/2023 00:06:48

Last indexation

31/10/2024 21:21:24
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated